Traded Apr 29 · filed 2 days laterNot under a reported trading plan
A 10% owner of Concentrix sold $134M of Concentrix shares. The filing does not indicate a pre-arranged trading plan.
Traded Jul 8, 2026 · Filed Jul 9, 2026
The CEO of Concentrix paid $21K out of pocket for Concentrix shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market purchase
Code P — open-market or private purchase
~$21,250
Shares × reported transaction price
<$25K
+0.3%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 4 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 5 earlier confirmed purchases
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
9 days after results of Jun 29, 2026, 83 days before results of Sep 29, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +10.1% | −1.5% | +11.6% |
| 30 days | +14.9% | +2.4% | +12.5% |
Past results only. Not a forecast.
Traded Apr 29 · filed 2 days laterNot under a reported trading plan
A 10% owner of Concentrix sold $134M of Concentrix shares. The filing does not indicate a pre-arranged trading plan.
Christopher A Caldwell, President and CEO's past purchases, 90 days after disclosure: 5 buys, median −16.1% vs S&P 500, beat it 0 of 5 times. Past results, not a forecast.